[VRDN] YoY Quarter Result on 30-Jun-2013 [#Q2]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
29-Jun-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -0.56%
YoY-
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 2,514 2,182 718 874 734 1,274 1,103 14.71%
PBT -8,896 -8,714 -7,312 -2,507 -2,562 -3,289 -540 59.48%
Tax 204 361 102 0 0 0 0 -
NP -8,896 -8,714 -7,312 -2,507 -2,562 -3,289 -540 59.48%
Tax Rate - - - - - - - -
Total Cost 11,410 10,896 8,030 3,381 3,296 4,563 1,643 38.10%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin -353.86 -399.36 -1,018.38 -286.84 -349.05 -258.25 -48.93 39.04%
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
EPS -4.31 -4.31 -5.12 -3.50 -4.94 -12.14 -2.87 7.00%
EPS Diluted -4.31 -4.31 -5.12 -3.50 -4.94 -12.14 -2.87 7.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.